Stay updated on Danicopan Early Access Program Clinical Trial
Sign up to get notified when there's something new on the Danicopan Early Access Program Clinical Trial page.

Latest updates to the Danicopan Early Access Program Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision: v3.4.2 has been added. The previous government-funding status notice has been removed.SummaryDifference0.6%

- Check32 days agoChange DetectedAdded a global site notice regarding funding-related updates and the NIH Clinical Center's status, and updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.6%

- Check39 days agoChange DetectedAdded a glossary display and new update-tracking fields (Last Update Submitted that Met QC Criteria, Last Update Posted), added No FEAR Act Data, and updated the page revision to v3.4.0, while removing older QC wording and the estimated last update entry.SummaryDifference0.4%

- Check54 days agoChange DetectedRevision: v3.3.4 is now shown on the page, replacing Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check75 days agoChange DetectedFooter updates: added 'Revision: v3.3.3' and removed 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'. No other content or functionality on the study details page was changed.SummaryDifference0.2%

- Check97 days agoChange DetectedThe changes involve metadata updates to the study record, including the addition of 'Last Update Posted (Estimated)' and the revision tag v3.3.2 with November 2025 dates, and removal of the earlier 'Last Update Posted' and revision v3.3.1 entries from April 2025. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Danicopan Early Access Program Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Danicopan Early Access Program Clinical Trial page.